Oncology Times - OncTimes Talk

Unknown

4.3 (3)
SCIENCE
UPDATED BIWEEKLY

OncTimes Talk features a variety of podcast series ranging from breaking news and oncology conference coverage to story round-ups and in-depth interviews with current experts and leaders in oncology.

JAN 25

KEYNOTE-006 Study 10-Year Survival Data Confirm PD-L1 Checkpoint Inhibition Best for Patients With Advanced Melanoma

Oncology Times - OncTimes Talk

8 min
JAN 13

Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified

Oncology Times - OncTimes Talk

16 min
JAN 10

Tumor-Agnostic Classifier & Screener Aids Targeted Drug Development

Oncology Times - OncTimes Talk

9 min
JAN 10

Early Switch to Immunotherapy Recommended After BRAFV600 Mutation Targeted Therapy for Advanced Melanoma

Oncology Times - OncTimes Talk

7 min
JAN 10

Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified

Oncology Times - OncTimes Talk

8 min
JAN 10

Clear Benefit From Early Checkpoint Inhibition in Locally Advanced, High-Risk Cervical Cancer

Oncology Times - OncTimes Talk

7 min
12/31/2024

The New Standard: Testing for All Therapy-Matched DNA and RNA Biomarkers Up Front

Oncology Times - OncTimes Talk

14 min
12/25/2024

Digital Twin Brings AI Power to Individualize Cancer Management

Oncology Times - OncTimes Talk

12 min

See All (185)

4.3

out of 5

3 Ratings

OncTimes Talk features a variety of podcast series ranging from breaking news and oncology conference coverage to story round-ups and in-depth interviews with current experts and leaders in oncology.

Creator

Unknown
Years Active

2012 - 2025
Episodes

185
Rating

Clean
Show Website

Oncology Times - OncTimes Talk

Careers

Careers

Updated Weekly
Health & Fitness

Health & Fitness

Updated Biweekly

Oncology Times - OncTimes Talk

KEYNOTE-006 Study 10-Year Survival Data Confirm PD-L1 Checkpoint Inhibition Best for Patients With Advanced Melanoma

Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified

Tumor-Agnostic Classifier & Screener Aids Targeted Drug Development

Early Switch to Immunotherapy Recommended After BRAFV600 Mutation Targeted Therapy for Advanced Melanoma

Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified

Clear Benefit From Early Checkpoint Inhibition in Locally Advanced, High-Risk Cervical Cancer

The New Standard: Testing for All Therapy-Matched DNA and RNA Biomarkers Up Front

Digital Twin Brings AI Power to Individualize Cancer Management

Ratings & Reviews

About

Information

You Might Also Like

Oncology Times - OncTimes Talk

Episodes

KEYNOTE-006 Study 10-Year Survival Data Confirm PD-L1 Checkpoint Inhibition Best for Patients With Advanced Melanoma

Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified

Tumor-Agnostic Classifier & Screener Aids Targeted Drug Development

Early Switch to Immunotherapy Recommended After BRAFV600 Mutation Targeted Therapy for Advanced Melanoma

Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified

Clear Benefit From Early Checkpoint Inhibition in Locally Advanced, High-Risk Cervical Cancer

The New Standard: Testing for All Therapy-Matched DNA and RNA Biomarkers Up Front

Digital Twin Brings AI Power to Individualize Cancer Management

Ratings & Reviews

About

Information

You Might Also Like